ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,478, issued on Feb. 24, was assigned to Karyopharm Therapeutics Inc. (Newton, Mass.).
"Co-crystal forms of selinexor" was invented by Clifton Hamilton (Devens, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to selinexor co-crystal forms; more particularly to two co-crystal forms with succinic acid as the coformer and a co-crystal form with vanillin as the coformer. The present disclosure is also related to processes for the preparation of selinexor co-crystal forms. Further, the present invention also relates to pharmaceutical compositions comprising a selinexor co-crystal form and method for treating disease ...